Organization
Santa Monica, CA
5 abstracts
Abstract
DIET2TREAT: A randomized, multi-center, phase 2 trial of a ketogenic diet vs standard dietary guidance in combination with standard-of-care treatment for patients with newly diagnosed glioblastoma.Org: Providence Saint John’s Health Center, Santa Monica, CA, Milwaukee, WI, Cedars-Sinai Cancer,
Abstract
Results of SOC-2082 phase 2 study using metronomic gemcitabine, doxorubicin and docetaxel plus nivolumab as second/third-line therapy for advanced sarcoma.Org: Sarcoma Oncology Research Center, Santa Monica, CA, Santa Monica, CA, City of Hope Comprehensive Cancer Center, Duarte, CA, Aveni Foundation,
Abstract
Artificial intelligence analysis of CCNG1 expression in tumors: A novel biomarker in development for anti-CCNG1 targeted therapy.Org: Sarcoma Oncology Research Center, Santa Monica, CA, Santa Monica, CA, Dornsife College of Letters, University of Southern California, Los Angeles, CA, University of California Los Angeles,
Abstract
Novel genomic alterations and transcriptomic-based tumor microenvironment classification of sarcoma and their impact on treatment decision making.Org: BostonGene, Corp., Waltham, MA, BostonGene Corporation, University of Texas MD Anderson Cancer Center, Houston, TX,
Abstract
Integration of breast-oncology clinical pathways in Providence Southern California clinical research network.Org: Saint John’s Cancer Institute at Providence Saint John’s Health Center, Santa Monica, CA, Providence California Regional Services, Irvine, CA, Providence Health and Services,